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Abstract
Background: Allergic diseases including allergic rhinitis, asthma, and atopic dermatitis are increasing worldwide.
Common medications used to treat these inflammatory disorders are anti-histamines and corticosteroids, but they
have their own limitations such as short duration and severe side effects. Thus, interest in complementary and
alternative medicine is continually growing. Here, we investigate the anti-inflammatory mechanisms of Tonggyu-
tang (TGT), a traditional Korean medicine that has been used to treat patients with allergic nasal disorders.
Methods: We measured mRNA expressions and production of pro-inflammatory cytokines such as interleukin (IL)-4,
IL-6, IL-8 and tumor necrosis factor alpha (TNF-α) by RT-PCR and ELISA assays in HMC-1 (human mast cell line-1)
and HaCaT cells, immortalized human keratinocytes. Moreover, we evaluated the effect of TGT on two major
inflammation-related pathways, mitogen activated protein kinase (MAPK) and NF-κB signaling pathway in these
two cells.
Results: Our results revealed that that TGT significantly reduced the expression and production of inflammatory
cytokines such as IL-4, IL-6, IL-8, and TNF-α in the agonist-treated HMC-1 and HaCaT cells. We also found that TGT
suppressed MAPK signaling pathway including extracellular signal-regulated kinase (ERK), p38 mitogen-activated
protein kinase (p38), and c-Jun N-terminal kinase (JNK) as well as NF-κB pathway, which are known to regulate
inflammatory cytokine expression.
Conclusion: Taken together, our results demonstrate that TGT inhibits expression of pro-inflammatory cytokines by
suppressing MAPK and NF-kB pathway in both mast cells and keratinocytes, suggesting the potential use of TGT in
treating allergic inflammatory diseases.
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Background
Allergic diseases are often caused by numerous inflam-
matory mediators such as histamine, chemokines, and
cytokines from immune cells, which are affected by in-
flammatory cytokines from T cells and immunoglobulin
E (IgE) from B cells [1, 2]. When the allergens enter the
human body, phagocytes such as dendritic cells and
macrophages process and present them to T cells, result-
ing in differentiation of naïve T cells into cytotoxic T
(Tc) cells or helper T (Th) cells. While activated Tc cells
kill infected cells, Th cells, especially Th2 cells, release
interleukin (IL)-4, IL-6 and IL-10 to induce B cells to
produce IgE, which in turn activates mast cells for hista-
mine secretion [3, 4].
Current medications commonly used to relieve symp-
toms of allergic reactions are anti-histamines and corti-
costeroids, but they have their own limitations such as
short duration and severe side effects [5, 6]. Thus, the
use of complementary and alternative medicine to treat
allergic diseases is largely gaining an interest. In trad-
itional Korean Medicine, several herbal medicines have
been used for the treatment of allergic inflammation.
Especially, Tonggyu-tang (TGT) composed of 12 herbs
(Table 1), similarly Pyeongwee-San [7], Biyeom-Tang [8],
Hyeonggaeyeongyo-Tang [9] and So-Cheon-Ryon-Tang
[10] have shown anti-inflammatory effects on patients
with allergic nasal disorder.
TGT was first seen in Dongeuibogam, seventeenth-
century textbook on Korean medicine, written by the
famous royal physician, Heo Joon [11]. In this study,
we modified ingredients of the original TGT by
adding Astragalus membranaceus var. mongholicus
Bung, Xanthium strumarium L., Magnolia denudate
Desr. and Mentha arvensis var. piperascens Makinv,
which are known to possess anti-inflammatory activ-
ities [12–16].
Although TGT has been commonly used for the
treatment of allergic diseases, its underlying molecular
mechanism of anti-inflammatory effect is unknown yet.
Therefore, we hereby investigate the anti-inflammatory
effect and the detailed molecular mechanism of TGT in
HMC-1 (human mast cell line-1) and HaCaT cells which
both participate in allergic disorders.
Methods
Chemicals and reagents
TGT was provided by Hanpoong pharmaceutical
company (Jeonju, Korea) in a form of powder, which
was dissolved in D.W. Phorbol 12-myristate 13-acetate
(PMA), dimethyl sulfoxide (DMSO), ionomycin, lipopoly-
saccharide (LPS) and 3-[4,5-dimetylthiazol-2-yl]-2,5-di-
phenyltetrazoliumbromide (MTT) were purchased from
Sigma-Aldrich Co. (St. Louis, MO, USA). Dulbecco’s
phosphate-buffered saline (DPBS), Iscove’s Modified
Dulbecco’s Medium (IMDM), Dulbecco’s Modified Eagle’s
medium (DMEM), penicillin and streptomycin were
obtained from WELGNE (Gyeongsan, Korea). 3-(4,5-di-
methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sul-
fophenyl)-2H–tetrazolium (MTT) was from Promega
(Maddison, WI, USA). Fetal bovine serum (FBS) was ob-
tained from GR scientific (Bedford, UK) and EZ-cytox was
purchased from DoGEN (Seoul, Korea). Human mRNA
primers (IL-4, IL-6, IL-8, IL-13, tumor necrosis factor
alpha (TNF-α), glyceraldehyde 3-phosphate dehydrogen-
ase (GAPDH) were purchased from Bioneer (Daejeon,
Korea). Antibodies were obtained from Cell signaling
Technology, Inc. (Danvers, MA, USA), and enzyme-linked
immunosorbent assays (ELISA) antibodies were obtained
from BD Biosciences (San Jose, CA, USA) and R&D
Systems (Minneapolis, MN, USA).
Cell culture and treatment
HMC-1 cells were grown in IMDM and HaCaT cells in
DMEM, all supplied with 1% penicillin and streptomycin
and 10% FBS, incubated at 37 °C, 5% CO2 and 95%
humidity. HMC-1 cells were stimulated with 5 ng/ml
horbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich,
St. Louis, MO, USA) plus 500 ng/ml ionomycin and
HaCaT cells were stimulated with 1 μg/ml LPS. After
stimulating cells, TGT was treated at various concentra-
tions for 24 h.




Ledebouriella divaricata Hiroe 6.46
Angelica koreanum Kitagawa 6.46
Angelica tenuissima Nakai 6.46 22
Cimicifuga heracleifolia Kom. 6.46
Pueraria thunbergiana Benth. 6.46 23
Ligusticum wallichii var. officinale Yook. 4.82
Atractylodes lancea DC. 9.69
Thuja orientalisl. 12.92 24–26
Ephedra sinica Stapf. 3.23 27, 28, 37
Zanthoxylum schinifolium S.Z. 3.23 29
Asarum sieboldii var. seoulense Nakai 2.58 30, 38
Glycyrrhiza glabra 6.46 31–34, 35
Astragalus membranaceus var.
mongholicus Bung
12.92 12, 13, 36, 39
Xanthium strumarium L. 6.46 14, 40
Magnolia denudate Desr. 2.94 15, 41
Mentha arvensis var. piperascens Makinv. 2.47 16, 42
Total 100
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Cell viability measurement with MTS assay or MTT assay
HMC-1 cells HaCaT cells were treated with various
concentrations of TGT (0, 10, 20, 50, 100, 200,500 and
1000 μg/ml) with or without 5 ng/ml PMA plus 500 ng/ml
ionomycin or LPS 1 μg/ml After 24 h, cells were treated
with MTS or MTT reagent solution for 1 h, then absorb-
ance was measured at 490 nm or 540 nm using a
microplate.
RNA extraction and RT-PCR
Total RNA was extracted using an R&A blue™ Total
RNA Extraction Kit (iNtRON Biotech, Korea). For
measurement of RNA concentration, a Nanodrop
1000 (Thermo Fisher scientific, Waltham, MA, USA)
was used. cDNA was prepared from 1 μg of total
RNA using a cDNA synthesis kit (Takara Bio Inc.,
Kusatsu, Japan). 1 μl of cDNA were used for RT-PCR
assays. The list of primers used in this study is shown
in Table 2.
Cytokine release measurement with ELISA
Enzyme-linked immunosorbent assay (ELISA) was
performed using kits from R&D systems (Minneapolis,
MN, USA) and BD Biosciences (San Jose, CA, USA).
Briefly, samples and cytokine standards were added in
96-well plates coated with coating buffer at 4 °C for
overnight and After washing with 0.05% Tween-20
phosphate-buffered saline (PBST) and blocked plates
using Assay diluent with antibodies of IL-4, IL-6, IL-
8, TNF-α (BD Biosciences, San Jose, CA, USA) and
IL-13 (R&D systems, Minneapolis, MN, USA), and
incubated at 37 °C for 1 h. After the plates were
washed, biotinylated antibodies were added and the
plates were left in RT for additional 2 h. The plates
were then washed, incubated with AP for 30 min at
37 °C. Then TBS substrate solution was added and
absorbance was measured at 450 nm by a microplate
reader.
Western blot assay
Cells were harvested, washed with 1 ml DPBS and
lysed with RIPA buffer (150 mM NaCl, 1% NP-40,
0.5% DOC, 0.1% SDS, 50 mM Tris (pH 8.0), 1 mM
EDTA, 1 mM PMSF, 1 mM NaF, 1 mM Na3PO4,
1 μg /ml aprotinin, leupeptin, pepstatin) and incu-
bated in ice for 20 min. Total cell lysates were then
centrifuged at 13,000×g for 20 min at 4 °C to remove
the insoluble materials. Next, the total concentration
of extracted proteins was determined at 15 μg, and
then separated by 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred onto nitrocellulose membranes. The mem-
branes were blocked with 0.1% PBST supplied with
2% skimmed milk and 2% bovine serum albumin
(BSA) (Sigma-Aldrich, St. Loius, MA, USA) for 1 h at
RT. After 4 times of 15 min washing with PBST, the
membranes were incubated with primary antibodies
diluted at 1:1000 at 4 °C overnight. After incubation,
the membranes were washed with PBS for 15 min, 4
times, and then incubated with secondary antibodies
diluted at 1:4000 for 1 h at RT. The protein signals
were developed by the ECL detection kit (DoGEN,
Seoul, Korea).
Statistical analysis
Results are expressed as the mean ± standard error
(S.E.) of independent experiments, and statistical ana-
lyses were performed using ONEWAY ANOVA to deter-
mine differences between groups. All statistical analyses
were performed using GraphPad Prism 5 (GraphPad
Software, Inc., La Jolla, CA, USA). Values with *p < 0.05
and #p < 0.05 are considered to indicate statistical
significance.
Results
Effect of TGT on expression and production of
inflammatory cytokines in HMC-1 cells
In order to examine the anti-inflammatory effects of
TGT, we used the human mast cell line-1, HMC-1
cells, one of the most representative cells for studying
inflammatory response. First, to evaluate the effect of
TGT on HMC-1 cell viability, an MTS assay was
performed. As a result, TGT did not affect HMC-1 viabil-
ity up to concentration of 1000 μg/ml (Additional file 1:
Fig. S1a). Next, to evaluate the anti-inflammatory ef-
fect of TGT, HMC-1 cells were stimulated with both
PMA and ionomycin (PI), followed by treatment with
various concentrations of TGT (100, 200, 500,
1000 μg/ml). As in Fig. 1a and b, PI treatment of
HMC-1 cells increased mRNA levels of IL-4, IL-6 and
TNF-α. Adding of TGT significantly reduced the
mRNA expression of these cytokines. Note that in the
Table 2 Reverse-Transcriptase PCR primer sequences of
oligonucleotide
Oligonucleotide
GAPDH F GCT CTT CAC CAC CAT GGA GA
R CGC CCA TCA CGC CAC AGT TT
IL-4 F TGC CTC CAA GAA CAC AAC TG
R CTC TGG TTG GCT TCC TTC AC
IL-6 F AAC CTT CCA AAG ATG GCT GAA
R CAG GAA CTG GAT CAG GAC TTT
IL-8 F TCA GTG CAT AAA GAC ATA CTCC
R TGG CAT CTT CAC TGA TTC TTG
TNF-α F TGA GCA CTG AAA GCA TGA TCC
R ATC ACT CCA AAG TGC AGC AG
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PI-treated HMC-1 cells, TGT did not cause
significant cell cytotoxicity up to 1000 μg/ml as well
(Additional file 1: Fig. S1b). Furthermore, we assessed
the effect of TGT on cytokine production by ELISA.
As shown in Fig. 2, TGT treatment significantly
reduced production of IL-4, IL-6 and TNF-α in the
PI-treated HMC-1 cells.
Effect of TGT on MAPK signaling pathway in HMC-1 cells
To understand the molecular mechanism underlying
the inhibitory effects of TGT on cytokine expression,
we examined the mitogen activated protein kinase
(MAPK) signaling pathway that is known to be
closely related to allergy diseases by regulating the
expressions of inflammatory cytokines such as TNF-α
and IL-6 [17, 18]. We observed that TGT treatment
of HMC-1 cells suppressed the PI-induced activation
of extracellular signal-regulated kinase (ERK), p38
mitogen-activated protein kinase (p38), and c-Jun N-
terminal kinase (JNK) in a dose-dependent manner
(Fig. 3a).
Effect of TGT on NF-κB signaling pathway in HMC-1 cells
NF-κB also plays a pivotal role in immune responses by
regulating the expressions of various inflammatory cyto-
kines. Under phosphorylated and degraded situations of
Fig. 1 Effect of TGT on expression of pro-inflammatory cytokines in PI stimulated HMC-1 cells. a PI-stimulated HMC-1 cells were treated with or
without different doses of TGT for 24 h. Cytokine mRNA levels were measured by RT-PCR. b The density of each band was calculated with image
processing program, Image J, and represented as bar graphs. *; compared to control. #; compared to stimulated cells. Control; HMC-1 with PI (−),
Stimulation; HMC-1 with PI (+)
Fig. 2 Effect of TGT on the release of pro-inflammatory cytokines in
HMC-1 cells. PI-stimulated HMC-1 cells were treated with or without
different doses of TGT for 24 h. The levels of secreted pro-inflammatory
cytokines in the cell culture supernatant were measured by ELISA.
*; compared to control. #; compared to stimulated cells. Control;
HMC-1 with PI (−), Stimulation; HMC-1 with PI (+)
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IκB, NF-κB are translocated into the nucleus, then initi-
ate inflammatory-related gene transcription [19, 20]. We
found that increased phosphorylation levels of IKKα/β,
IκBα/β, as well as STAT3 by PI treatment were inhibited
by TGT co-treatment in a dose-dependent manner in
HMC-1 cells (Fig. 3b).
Effect of TGT on inflammatory cytokines in HaCaT cells
Given that TGT suppresses the cytokine expression in
HMC-1 cells, we next investigated the inhibitory effect
of TGT on cytokine expression in HaCaT cells, an im-
mortalized human keratinocytes. Of note, TGT did not
show significant cytotoxicity in mock or LPS-treated
HaCaT cells (Additional file 2: Fig. S2). Similar to HMC-
1 cells, treatment of HaCaT cells with TGT markedly
reduced the LPS-induced expression and production of
inflammatory cytokines including IL-4, IL-6, IL-8 and
TNF-α, as measured by RT-PCR and ELISA, respectively
(Figs. 4 and 5).
Discussion
Allergic diseases such as allergic rhinitis, atopic derma-
titis and asthma share a number of pathogenic and
epidemiological features. Although detailed mechanisms
of these diseases at the cellular level are still unclear, re-
cent studies have focused on the roles of immune cells,
especially Th2 cells in the pathogenesis of these allergic
disorders [21].
TGT is an herbal medicine composed of 12 different
herbs that are frequently used for treatment of patients
with nasal disorder [11]. In this study, we added 4
additional anti-inflammatory herbs including Astragalus
membranaceus, Xanthium strumarium, Magnolia denu-
date, and Mentha arvensis, to the original constituents
to increase TGT’s anti-allergic effects. Among these 16
herbs in the formulation of TGT, a number of studies
Fig. 3 Effect of TGT on the protein expressions of MAPK and NF-κB signaling pathways in HMC-1 cells. PI-stimulated HMC-1 cells were treated
with or without different doses of TGT for 24 h. The levels of protein expressions of (a) MAPK signaling pathway and (b) NF-κB signaling pathway
in the whole cell lysates of HMC-1 cells were measured by western blot assays
Fig. 4 Effect of TGT on expression of pro-inflammatory cytokines in
LPS stimulated HaCaT cells. a LPS-stimulated HaCaT cells were treated
with or without different doses of TGT for 24 h. Cytokine mRNA levels
were measured by RT-PCR. b The density of each band was calculated
with image processing program, Image J, and represented as bar
graph. *; compared to control. #; compared to stimulated cells. Control;
HaCaT with LPS (−), Stimulation; HaCaT with LPS (+)
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have showed that extracts or an active compound
from individual herbs have anti-inflammatory activ-
ities (Table 1) [12–16, 22–36]. Especially, six herbs
including Ephedra sinica and Asarum sieboldii have
been reported to have anti-histamine actions like
inhibition of histamine release from mast cells or sev-
eral histamine-mediated biological processes [37–42].
Since no studies have been performed to examine
cellular and molecular actions of TGT, we sought to
investigate the effects of TGT on human mast cells and
keratinocytes. Mast cells play a key role in the develop-
ment of allergic responses by releasing inflammatory
mediators such as TNF-α, IL-6, IL-8, IL-13, and hista-
mine [43, 44]. IL-6 stimulates the growths of neutrophils
and B cells, and IL-13 influence the apoptosis and sur-
vival of eosinophils, respectively [45–47].
In this study, we showed that TGT significantly
reduced the expression and production of inflammatory-
cytokines in both HMC-1 and HaCaT cells. MAPK such
as ERK, p38, and JNK are closely involved in the synthe-
sis of inflammation mediators. Therefore, inhibitors tar-
geting MAPKs are developed to reduce inflammation
[48]. Our findings showed that TGT inhibits agonist-
induced MAPK activation in a dose-dependent manner.
Furthermore, we found that TGT treatment suppressed
the agonist-induced activation of NF-κB pathway which
is another important cellular signaling pathway for pro-
duction of inflammatory cytokines. Overall, our results
suggest that TGT can be effective treatment option for
patients with inflammatory disorders including allergic
rhinitis, atopic dermatitis through suppressing MAPK
and NF-κB mediated production of inflammatory cyto-
kines.
Conclusions
Our results clearly indicate that TGT has suppressing ac-
tivity on expression and production of pro-inflammatory
cytokines through inhibition of MAPK and NF-κB
signaling pathways in mast cells and keratinocytes.
Therefore, TGT can be used to reduce inflammatory
symptoms in allergic disorders including not only
allergic rhinitis but also atopic dermatitis and asthma.
Additional files
Additional file 1: Figure S1. Effect of TGT on the viability of PMA and
Ionomycin (PI)-stimulated HMC-1 cells. Various concentration of TGT was
added to PI treated HMC-1 cells. Cell viability was measured by MTS
assay. *; compared to control. #; compared to stimulated cells. Control;
HMC-1 with PI (−), Stimulation; HMC-1 with PI (+). (TIFF 82 kb)
Additional file 2: Figure S2. Effect of TGT on the viability of LPS-
stimulated HaCaT cells. Various concentration of TGT was added to LPS
treated HaCaT cells. Cell viability was measured by MTT assay. *; compared
to control. #; compared to stimulated cells. Control; HaCaT with LPS (−),
Stimulation; HaCaT with LPS (+). (TIFF 91 kb)
Abbreviations
ANOVA: One-way analysis of variance; DMEM: Dulbecco’s Modified Eagle’s
medium; DMSO: dimethyl sulfoxide; DPBS: Dulbecco’s phosphate-buffered
saline; ELISA: enzyme-linked immunosorbent assays; ERK: extracellular signal-
regulated kinase;; FBS: fetal bovine serum; GAPDH: glyceraldehyde 3-
phosphate dehydrogenase; HMC-1: human mast cell line-1;
Fig. 5 Effect of TGT on the release of pro-inflammatory cytokines in HaCaT cells. LPS-stimulated HaCaT cells were treated with or without different
doses of TGT for 24 h. The levels of secreted pro-inflammatory cytokines in the cell culture supernatant were measured by ELISA. *; compared to
control. #; compared to stimulated cells. Control; HaCaT with LPS (−), Stimulation; HaCaT with LPS (+)
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IgE: immunoglobulin E; IL: Interleukin; IMDM: Iscove’s Modified Dulbecco’s
Medium; JNK: c-Jun N-terminal kinase; LPS: Lipopolysaccharide;
MAPK: Mitogen activated protein kinase; MTS: 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H–tetrazolium; MTT: 3-[4,5-
dimetylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide; p38: p38 mitogen-
activated protein kinase; PBST: Tween-20 phosphate-buffered saline; PI: PMA
and ionomycin; PMA: Phorbol 12-myristate 13-acetate; SDS-PAGE: sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE); Tc: Cytotoxic
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